Phibro Animal Health | PAHC - Ordinary Share Capital


Phibro Animal Health reported $40.48M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Align Technology USD 71.75M 736K Dec/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Assertio Holdings USD 9K 0 Dec/2023
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Henry Schein USD 115.77M 2.8M Dec/2025
Idexx Laboratories USD 79.85M 154K Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Pacira USD 41.12M 1.85M Dec/2025
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Zoetis USD 424.93M 16.54M Dec/2025